The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin lar     Quarter: 2016Q3

Total Records: 1,320     Number of Pages: 66

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Metastases to chest wall 2
SANDOSTATIN LAR DEPOT Metastatic neoplasm 2
SANDOSTATIN LAR DEPOT Micturition disorder 2
SANDOSTATIN LAR DEPOT Multi-organ disorder 2
SANDOSTATIN LAR DEPOT Multiple endocrine neoplasia 2
SANDOSTATIN LAR DEPOT Musculoskeletal disorder 2
SANDOSTATIN LAR DEPOT Nail bed disorder 2
SANDOSTATIN LAR DEPOT Nasal discharge discolouration 2
SANDOSTATIN LAR DEPOT Nasal dryness 2
SANDOSTATIN LAR DEPOT Nephrosclerosis 2
SANDOSTATIN LAR DEPOT Oesophageal pain 2
SANDOSTATIN LAR DEPOT Oesophageal spasm 2
SANDOSTATIN LAR DEPOT Onychoclasis 2
SANDOSTATIN LAR DEPOT Optic nerve disorder 2
SANDOSTATIN LAR DEPOT Oral infection 2
SANDOSTATIN LAR DEPOT Osteosclerosis 2
SANDOSTATIN LAR DEPOT Overdose 2
SANDOSTATIN LAR DEPOT Papillary thyroid cancer 2
SANDOSTATIN LAR DEPOT Papule 2
SANDOSTATIN LAR DEPOT Pelvic pain 2

Total Records: 1,320     Number of Pages: 66